Trial · NCT04150107
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1- Placebo run-in (All Patients) | STARTED | Placebo Followed by Treatment A Followed by Treatment B | 14 | |
| Period 1- Placebo run-in (All Patients) | STARTED | Placebo Followed by Treatment B Followed by Treatment A | 16 | |
| Period 1- Placebo run-in (All Patients) | COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 14 | |
| Period 1- Placebo run-in (All Patients) | COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 16 | |
| Period 1- Placebo run-in (All Patients) | NOT COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 0 | |
| Period 1- Placebo run-in (All Patients) | NOT COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 0 | |
| Period 2- Either Treatment A or B | STARTED | Placebo Followed by Treatment A Followed by Treatment B | 14 | |
| Period 2- Either Treatment A or B | STARTED | Placebo Followed by Treatment B Followed by Treatment A | 16 | |
| Period 2- Either Treatment A or B | COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 14 | |
| Period 2- Either Treatment A or B | COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 16 | |
| Period 2- Either Treatment A or B | NOT COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 0 | |
| Period 2- Either Treatment A or B | NOT COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 0 | |
| Period 3 Crossover-Treatment B or A | STARTED | Placebo Followed by Treatment A Followed by Treatment B | 14 | |
| Period 3 Crossover-Treatment B or A | STARTED | Placebo Followed by Treatment B Followed by Treatment A | 16 | |
| Period 3 Crossover-Treatment B or A | COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 12 | |
| Period 3 Crossover-Treatment B or A | COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 15 | |
| Period 3 Crossover-Treatment B or A | NOT COMPLETED | Placebo Followed by Treatment A Followed by Treatment B | 2 | |
| Period 3 Crossover-Treatment B or A | NOT COMPLETED | Placebo Followed by Treatment B Followed by Treatment A | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04150107/flow